Baker Brothers Life Sciences Capital (GP), LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is a Director in INCYTE CORP ($INCY) and a Director in NEUROGEN CORP ($NRGN) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Address: 667 MADISON AVENUE 17TH FLOOR NEW YORK 10021 NY
Companies in which Baker Brothers Life Sciences Capital (GP), LLC is an Insider
Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 608,152 shares
Latest Transaction: Apr 28 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 5,773,365 shares
Latest Transaction: Mar 10 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 713,044 shares
Current Value: $19,601,580
Latest Transaction: Sep 11 2006
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 11,175,900 shares
Current Value: $17,434,404
Latest Transaction: Aug 17 2006
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 8,929,705 shares
Current Value: $1,055,312,537
Latest Transaction: Sep 28 2009
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROGEN CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 2,307,661 shares
Latest Transaction: Apr 28 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 4,149,611 shares
Current Value: $252,254,853
Latest Transaction: Aug 16 2006
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 1,228,857 shares
Latest Transaction: Apr 28 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TAPESTRY PHARMACEUTICALS, INC
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 1,844,485 shares
Latest Transaction: Apr 28 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC
Sentiment: All, IBPI, AUXL, GHDX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.75 | 550,000 | 12,513,765 | 5,773,365 | 5.2 M to 5.8 M (+10.53 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.44 | 115,000 | 2,695,060 | 5,223,365 | 5.1 M to 5.2 M (+2.25 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.17 | 117,273 | 2,717,344 | 5,108,365 | 5 M to 5.1 M (+2.35 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.81 | 58,388 | 1,331,976 | 4,991,092 | 4.9 M to 5 M (+1.18 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.51 | 1,948 | 43,845 | 4,932,704 | 4.9 M to 4.9 M (+0.04 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.86 | 48,657 | 1,112,299 | 4,930,756 | 4.9 M to 4.9 M (+1.00 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.88 | 86,227 | 1,972,693 | 4,882,099 | 4.8 M to 4.9 M (+1.80 %) |
View all Baker Brothers Life Sciences Capital (GP), LLC insider transactions.